Skip to content
10-K

Annual Report

Structure Therapeutics Inc. GPCR

0001558370-25-001826

← back to feed
Filed
Feb 27, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2024 · Jan 31, 2025 172.03M sh
Short Term Investments FY 2024 · Dec 31, 2023 $337.53M
Cash And Equivalents FY 2024 · Dec 31, 2023 $129.79M
Current Liabilities FY 2024 · Dec 31, 2023 $24.74M
Total Liabilities FY 2024 · Dec 31, 2023 $29.05M
Current Assets FY 2024 · Dec 31, 2023 $473.61M
Total Assets FY 2024 · Dec 31, 2023 $482.02M